|
May 1
|
Emergent BioSolutions Releases New Survey Findings Underscoring the Need to Continue Expanding Access & Increasing Awareness to Naloxone
|
|
Apr 30
|
Emergent BioSolutions Announces Amendment to its Existing Credit Facility
|
|
Apr 22
|
Emergent BioSolutions to Release First Quarter 2024 Financial Results & Conduct Conference Call on May 1, 2024
|
|
Apr 17
|
Institutional owners may take dramatic actions as Emergent BioSolutions Inc.'s (NYSE:EBS) recent 16% drop adds to one-year losses
|
|
Apr 1
|
Aquestive Therapeutics Strengthens Board of Directors with Experienced Biotech Executive
|
|
Mar 28
|
Emergent BioSolutions Continues to Broaden Access, Awareness and Availability of NARCAN® Nasal Spray to Help Save Lives from the Ongoing Opioid Crisis
|
|
Mar 25
|
Emergent BioSolutions Receives NAI Status for Baltimore Bayview Manufacturing Facility
|
|
Mar 7
|
Emergent BioSolutions Inc (EBS) Reports Mixed Fourth Quarter and Full Year 2023 Financial Results
|
|
Mar 7
|
Emergent (EBS) Down 16% on Q4 Earnings Miss, Tops on Sales
|
|
Mar 7
|
Emergent BioSolutions Inc. (NYSE:EBS) Q4 2023 Earnings Call Transcript
|
|
Mar 7
|
Q4 2023 Emergent BioSolutions Inc Earnings Call
|
|
Mar 7
|
Emergent BioSolutions (EBS) Q4 2023 Earnings Call Transcript
|
|
Mar 6
|
Emergent Biosolutions (EBS) Reports Q4 Loss, Tops Revenue Estimates
|
|
Mar 6
|
Emergent BioSolutions Reports Fourth Quarter 2023 Financial Results
|
|
Jan 12
|
Emergent (EBS) Gets $235.8M DoD Contract for Anthrax Vaccine
|
|
Jan 11
|
Emergent BioSolutions Awarded Procurement Contract Valued up to $235.8 Million to Supply BioThrax® (Anthrax Vaccine Adsorbed) to the U.S. Department of Defense
|
|
Jan 9
|
Emergent BioSolutions to Present at the 42nd Annual J.P. Morgan Healthcare Conference on January 11, 2024
|
|
Dec 11
|
Emergent Biosolutions (EBS) Reports Q3 Loss, Tops Revenue Estimates
|
|
Nov 29
|
Emergent (EBS) Gets $75M BARDA Contract for Anthrax Vaccine
|
|
Nov 28
|
Emergent BioSolutions Receives $75 Million Contract Option from BARDA to Procure Doses of CYFENDUS™ (Anthrax Vaccine Adsorbed, Adjuvanted)
|